Abbott says holders may put three series of Advanced Medical Optics convertibles

By Susanna Moon

Chicago, Feb. 27 - Abbott Laboratories said it may be required to repurchase three series of Advanced Medical Optics Inc.'s convertible notes in connection with its acquisition of the company.

Advanced Medical holders may put their 2.5% convertible senior subordinated notes due 2024, 1.375% convertible senior subordinated notes due 2025 and 3.25% convertible senior subordinated notes due 2026. The put option was triggered as a result of the fundamental change under terms of the notes.

The offer will expire at 5 p.m. ET on March 27. It began Friday.

The company will pay par plus accrued interest to the repurchase date, which is March 30.

U.S. Bank NA is the paying agent.

Holders may convert their notes until March 12.

Abbott said the notes are convertible into cash at par for the 2.5% convertibles, $462.1848 per $1,000 principal amount of the 1.375% convertibles and $369.0962 per $1,000 principal amount of the 3.25% convertibles. No accrued interest is payable to holders for the conversion of the notes.

On Jan. 12, Abbott announced it would acquire Advanced Medical for $2.8 billion, including net debt.

Advanced Medical is now called Abbott Medical Optics.

Abbott's $22-per-share cash tender offer for Advanced Medical expired at midnight ET on Feb. 24. The offer began on Jan. 27.

Santa Ana, Calif.-based Advanced Medical operates in three segments: cataract surgery, Lasik and eye-care products.

Abbott is a biopharmaceutical company located in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.